Should You Buy Brainstorm Cell Therapeutics Inc (BCLI) in Biotechnology Industry?

by InvestorsObserver, Benzinga Columnist

March 31, 2023 10:06 AM | 16 seconds read | Make a Comment

Brainstorm Cell Therapeutics Inc (BCLI) is near the top in its industry group according to InvestorsObserver. BCLI gets an overall rating of 74. That means it scores higher than 74 percent of stocks. Brainstorm Cell Therapeutics Inc gets a 89 rank in the Biotechnology industry. Biotechnology is number 35 out of 148 industr

Market News and Data brought to you by Benzinga APIs

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Should You Buy Brainstorm Cell Therapeutics Inc (BCLI) in Biotechnology Industry?